IBDEI1TG ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29013,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29013,1,2,0)
 ;;=2^97533
 ;;^UTILITY(U,$J,358.3,29013,1,3,0)
 ;;=3^Sensory Integrative Techniques,per 15 min
 ;;^UTILITY(U,$J,358.3,29014,0)
 ;;=97537^^117^1451^1^^^^1
 ;;^UTILITY(U,$J,358.3,29014,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29014,1,2,0)
 ;;=2^97537
 ;;^UTILITY(U,$J,358.3,29014,1,3,0)
 ;;=3^Community/Work Reintegration,Ea 15 min
 ;;^UTILITY(U,$J,358.3,29015,0)
 ;;=97545^^117^1451^6^^^^1
 ;;^UTILITY(U,$J,358.3,29015,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29015,1,2,0)
 ;;=2^97545
 ;;^UTILITY(U,$J,358.3,29015,1,3,0)
 ;;=3^Work Hardening/Conditioning,Init 2 hrs
 ;;^UTILITY(U,$J,358.3,29016,0)
 ;;=97546^^117^1451^7^^^^1
 ;;^UTILITY(U,$J,358.3,29016,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29016,1,2,0)
 ;;=2^97546
 ;;^UTILITY(U,$J,358.3,29016,1,3,0)
 ;;=3^Work Hardening/Conditioning,Ea Addl Hr
 ;;^UTILITY(U,$J,358.3,29017,0)
 ;;=98961^^117^1451^3^^^^1
 ;;^UTILITY(U,$J,358.3,29017,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29017,1,2,0)
 ;;=2^98961
 ;;^UTILITY(U,$J,358.3,29017,1,3,0)
 ;;=3^Self-Mgmt Educ/Trng,2-4 Pts,Ea 30 min
 ;;^UTILITY(U,$J,358.3,29018,0)
 ;;=98962^^117^1451^4^^^^1
 ;;^UTILITY(U,$J,358.3,29018,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29018,1,2,0)
 ;;=2^98962
 ;;^UTILITY(U,$J,358.3,29018,1,3,0)
 ;;=3^Self-Mgmt Educ/Trng,5-8 Pts,Ea 30 min
 ;;^UTILITY(U,$J,358.3,29019,0)
 ;;=99078^^117^1451^2^^^^1
 ;;^UTILITY(U,$J,358.3,29019,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29019,1,2,0)
 ;;=2^99078
 ;;^UTILITY(U,$J,358.3,29019,1,3,0)
 ;;=3^Group Health Education/Counseling
 ;;^UTILITY(U,$J,358.3,29020,0)
 ;;=96372^^117^1452^1^^^^1
 ;;^UTILITY(U,$J,358.3,29020,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29020,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,29020,1,3,0)
 ;;=3^Ther/Proph/Diag Inj SC/IM
 ;;^UTILITY(U,$J,358.3,29021,0)
 ;;=96402^^117^1452^2^^^^1
 ;;^UTILITY(U,$J,358.3,29021,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29021,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,29021,1,3,0)
 ;;=3^Anti-Neoplastic,Hormonal,IM
 ;;^UTILITY(U,$J,358.3,29022,0)
 ;;=J1630^^117^1452^3^^^^1
 ;;^UTILITY(U,$J,358.3,29022,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29022,1,2,0)
 ;;=2^J1630
 ;;^UTILITY(U,$J,358.3,29022,1,3,0)
 ;;=3^Haloperidol,up to 5mg
 ;;^UTILITY(U,$J,358.3,29023,0)
 ;;=J1631^^117^1452^4^^^^1
 ;;^UTILITY(U,$J,358.3,29023,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29023,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,29023,1,3,0)
 ;;=3^Haloperidol Decanoate,per 50mg
 ;;^UTILITY(U,$J,358.3,29024,0)
 ;;=J2680^^117^1452^5^^^^1
 ;;^UTILITY(U,$J,358.3,29024,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29024,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,29024,1,3,0)
 ;;=3^Fluphenazine Decanoate,up to 25mg
 ;;^UTILITY(U,$J,358.3,29025,0)
 ;;=J2794^^117^1452^6^^^^1
 ;;^UTILITY(U,$J,358.3,29025,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29025,1,2,0)
 ;;=2^J2794
 ;;^UTILITY(U,$J,358.3,29025,1,3,0)
 ;;=3^Risperidone,Long Acting,per 0.5mg
 ;;^UTILITY(U,$J,358.3,29026,0)
 ;;=90867^^117^1453^3^^^^1
 ;;^UTILITY(U,$J,358.3,29026,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29026,1,2,0)
 ;;=2^90867
 ;;^UTILITY(U,$J,358.3,29026,1,3,0)
 ;;=3^TMS,Initial
 ;;^UTILITY(U,$J,358.3,29027,0)
 ;;=90868^^117^1453^4^^^^1
 ;;^UTILITY(U,$J,358.3,29027,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29027,1,2,0)
 ;;=2^90868
 ;;^UTILITY(U,$J,358.3,29027,1,3,0)
 ;;=3^TMS,Subseq Delivery & Mgmt,per session
